The Characteristics of Cardiovascular Adverse Events in Therapy with Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team. (2024). Voprosy Onkologii, 70(3), 541-549. https://doi.org/10.37469/0507-3758-2024-70-3-541-549